Committed to the delivery of Precision Medicine for cancer care, Yatin Mundkur leads Cellworks Group in transforming the treatment of cancer through personalized medicine. As CEO of Cellworks, Yatin Mundkur develops company strategy and commercialization of both its Precision Medicine and its Stratified Medicine businesses.
Over the last 25 years, Yatin has launched businesses in medical diagnostics, technology and communications, delivering strong returns to investors consistently. As a Partner of Artiman Ventures he focuses on early-stage Technology and Healthcare investments.
He is also on the Boards of Prysm, mSupply, Virsec, Xambala, Yantra and zSpace. Prior to joining Artiman Ventures, Yatin Mundkur was Managing Director at TeleSoft Partners, where he led investments in over twenty companies, in the early stage semiconductor and software sectors. Formerly, he held executive and engineering roles in multiple technology companies.
He has been awarded fourteen patents, in the areas of computer architectures, digital consumer electronics, semiconductor design, and software. Yatin holds a B.S.E.E. from MSU of Baroda, India, and a M.S.E.E. from the University of Texas at Austin.